Neuroendocrine cancer: SELECT—lenvatinib in thyroid cancer
- PMID: 25707627
- DOI: 10.1038/nrclinonc.2015.30
Neuroendocrine cancer: SELECT—lenvatinib in thyroid cancer
Comment on
-
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.N Engl J Med. 2015 Feb 12;372(7):621-30. doi: 10.1056/NEJMoa1406470. N Engl J Med. 2015. PMID: 25671254 Clinical Trial.
References
-
- N Engl J Med. 2015 Feb 12;372(7):621-30 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
